Citadel Advisors
MOLN

Citadel Advisors’s Molecular Partners MOLN Stock Holding History

Citadel Advisors’s Portfolio MOLN Stock Details MOLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.3K Buy
+17,179
New +$69.7K ﹤0.01% 12986

Other funds holding MOLN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's MOLN Position: Q2 2026 in Review

Citadel Advisors opened a new position in Molecular Partners (MOLN) in Q2 2026: 17,179 shares worth $65.3K. The stake represents ﹤0.01% of the portfolio and ranks #12986 among its holdings.

5 funds tracked by Wall St. Rank hold MOLN as of Q2 2026.

  • Citadel Advisors held 17,179 shares of Molecular Partners worth $65.3K as of Q2 2026.
  • Molecular Partners was a new Citadel Advisors position in Q2 2026.
  • Molecular Partners made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12986 holding.
  • 5 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.